Press release
Global Hyperkalemia Treatment Market Research Report 2023
The global Hyperkalemia Treatment market was valued at US$ 540 million in 2022 and is anticipated to reach US$ 2068.8 million by 2029, witnessing a CAGR of 20.9% during the forecast period 2023-2029.
Hyperkalemia Treatment Market
Hyperkalemia is a diseases in which levels of potassium are higher than normal level (3.5 and 5.0 mmol/L) in blood serum. Kidneys are responsible for managing potassium balance in the body by regulating its excretion as well as its intake. A person is prone to develop hyperkalemia when the consumption of potassium exceeds that of kidneys' potential to excrete it. The right amount of potassium and sodium in the body play a vital role in normal functioning of the myocardium.
Hyperkalemia can occur due to congestive heart failure, chronic kidney disease, or diabetic kidney disease. The condition can also occur when a patient receives renin-angiotensin-aldosterone system inhibitors (RAAS) in kidney disease. Abnormal levels of potassium can lead to irregular heartbeats, which can be fatal. Hyperkalemia is diagnosed by kidney functioning test, creatinine blood test, blood tests, and glucose monitoring.
The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The main manufacturers of Global Hyperkalemia Treatment include Vifor Pharma, Astrazeneca, etc. These top two manufacturers hold a market share about 50%. North America and Europe are the major producing regions in the world.
VIEW REPORT :
https://reports.valuates.com/market-reports/QYRE-Auto-9L9341/global-hyperkalemia-treatment
Report Scope
This report aims to provide a comprehensive presentation of the global market for Hyperkalemia Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hyperkalemia Treatment.
The Hyperkalemia Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Hyperkalemia Treatment market comprehensively. Regional market sizes, concerning products by type, by distribution channel and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hyperkalemia Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by distribution channel and by regions.
GET FREE SAMPLE :
https://reports.valuates.com/market-reports/QYRE-Auto-9L9341/global-hyperkalemia-treatment
Segment by Type
Patiromer
Sodium Zirconium Cyclosilicate
Segment by Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Consumption by Region
North America (United States, Canada)
Europe (Germany, France, UK, Italy, Russia)
Asia-Pacific (China, Japan, South Korea, Taiwan)
Southeast Asia (India)
Latin America (Mexico, Brazil)
By Company Vifor Pharma, Astrazeneca, Sanofi, CMP Pharma, Belcher Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends
SIMILAR REPORTS :
https://reports.valuates.com/market-reports/QYRE-Auto-9E15495/global-coronary-guide-catheter
https://reports.valuates.com/market-reports/QYRE-Auto-22K15111/global-electrophysiology-mapping-catheter-and-ablation-catheter
https://reports.valuates.com/market-reports/QYRE-Auto-36L15198/global-borrelia-burgdorferi-test-kit
Valuates Reports
sales@valuates.com
For U.S. Toll-Free Call 1-(315)-215-3225
For IST Call +91-8040957137
WhatsApp: +91-9945648335
Website: https://reports.valuates.com
Twitter - https://twitter.com/valuatesreports
Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.
Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that's why we offer customization of reports. With our customization in place, you can request for any particular information from a report that meets your market analysis needs.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Hyperkalemia Treatment Market Research Report 2023 here
News-ID: 3217622 • Views: …
More Releases from Valuates Reports
Consumer Grade Ethernet PHY Chip Market Revenue Share, Insights & Future Outlook
Consumer Grade Ethernet PHY Chip Market Size
The global market for semiconductor was estimated at US$ 579 billion in the year 2022, is projected to US$ 790 billion by 2029, growing at a CAGR of 6% during the forecast period.
Download Free Sample Data: https://reports.valuates.com/request/sample/QYRE-Auto-20H13888/Global_Consumer_Grade_Ethernet_PHY_Chip_Market?utm_source=Openpr&utm_medium=Referral
Report Scope
This report aims to provide a comprehensive presentation of the global market for Consumer Grade Ethernet PHY Chip, with both quantitative and qualitative analysis, to help readers…
Gas Station POS System Market Set to Surge - Key Insights You Must Know
Gas Station POS System Market Size
The global market for Gas Station POS System was valued at US$ 609 million in the year 2024 and is projected to reach a revised size of US$ 1125 million by 2031, growing at a CAGR of 9.3% during the forecast period.
Download Free Sample Data: https://reports.valuates.com/request/sample/QYRE-Auto-21T13110/Global_Gas_Station_POS_System_Market?utm_source=Openpr&utm_medium=Referral
By Type
• Cloud Based
• Web Based
By Application
• Large Gas Station
• Small and Medium Gas Stations
Key Companies
Verifone, Gas Pos, LS Retail, NCR, Gilbarco Veeder-Root, PDI…
UHMWPE Rope Market Set to Surge - Key Insights You Must Know
UHMWPE Rope Market Size
The global market for UHMWPE Rope was estimated to be worth US$ 201 million in 2024 and is forecast to a readjusted size of US$ 315 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Download Free Sample Data: https://reports.valuates.com/request/sample/QYRE-Auto-31C10201/Global_UHMWPE_Rope_Market?utm_source=Openpr&utm_medium=Referral
UHMWPE is odorless, tasteless, and nontoxic. It is highly resistant to corrosive chemicals except oxidizing acids, has extremely low moisture absorption (Hydrophobic), very low coefficient…
Baking Mixes Market Set to Surge - Key Insights You Must Know
Baking Mixes Market Size
The global Baking Mixes market was valued at US$ 2914.8 million in 2023 and is anticipated to reach US$ 3912.6 million by 2030, witnessing a CAGR of 3.8% during the forecast period 2024-2030.
Download Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-5V8719/Global_Baking_Mixes_Market?utm_source=Openpr&utm_medium=Referral
The major global manufacturers of Baking Mixes include General Mills, Cargill, Archer Daniels Midland, Ingredion, Hain Celestial Group, Associated British Foods, Pinnacle Foods, Chelsea Milling Company and Dawn Food Products, etc. In…
More Releases for Hyperkalemia
Hyperkalemia Treatment Market Moving in the Right Direction: AstraZeneca, Ardely …
The latest study released on the Global Hyperkalemia Treatment Market by HTF MI Research evaluates market size, trend, and forecast to 2030. The Hyperkalemia Treatment market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors.
Key Players…
Hyperkalemia Drugs Market Size, Share, Industry, Forecast and outlook (2024-2031 …
Global Hyperkalemia Drugs Market to Surpass US$ Million Mark by 2030, Reveals New Market Report
The hyperkalemia drugs market, valued at US$ million in 2023, is anticipated to achieve a significant milestone, reaching US$ million by 2030, showcasing a robust CAGR growth during the forecast period of 2024-2031.
Hyperkalemia, characterized by elevated levels of potassium in the bloodstream, poses severe health risks including life-threatening cardiac arrhythmias and paralysis, primarily attributed to impaired…
Hyperkalemia Market to Reach US$ 2,320.5 Million by 2033 | IMARC Group
The newly published report by IMARC Group, titled "Hyperkalemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033″, presents a comprehensive analysis of the hyperkalemia market. The report provides an overview of the market trends, growth prospects, investment opportunities, and industry prospects, as well as an analysis of the disease overview, market scenario, and growth trends. In addition, the report offers competitor analysis, regional analysis, and recent advancements…
Hyperkalemia Treatment Market Size, Share, Industry, Forecast to 2030
The Hyperkalemia Treatment Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global Hyperkalemia Treatment market. This report explores all the key factors affecting the growth of the global Hyperkalemia Treatment market, including…
Global Hyperkalemia Supplement Market, Size, Share, Analysis Report & Forecast t …
The global hyperkalemia treatment market is anticipated to grow at a significant CAGR during the forecast period. The major factor for the growth of the market is the increasing chronic diseases such as acute hyperkalemia and chronic hyperkalemia due to other ailments such as diabetes, consumption of high potassium diets, and many other things. As per the National Kidney Foundation, more than 37 million people in the United States have…
Hyperkalemia Therapeutics - Pipeline Analysis 2018 | Ardelyx, Inc., Relypsa
Hyperkalemia is referred to as increased levels of potassium in blood which results in cardiac arrest and death. Potassium levels above 5.1 mEq/l are considered as the hyperkalemia condition.
Download the sample report @ https://www.pharmaproff.com/request-sample/1155
The main causes of hyperkalemia are potassium sifting out of cells into the blood circulation, adrenal gland diseases, kidney dysfunction, uncontrolled diabetes, breakdown of muscle tissue and red blood cells. Hyperkalemia causes abnormal heart rhythms and…
